Influence of Mesenchymal stem cells with endothelial progenitor cells in co-culture on osteogenesis and angiogenesis: An in vitro study

Archives of Medical Research

Volumn 44, Issue 7, 2013, Pages 504-513

  Li, Qiong ^a   Wang, Zuolin ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Angiogenesis; Endothelial progenitor cells; Mesenchymal stem cells; Osteogenesis; Tissue engineering

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MATRIGEL; OSTEOCALCIN; SOMATOMEDIN C; STROMELYSIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL COMMUNICATION; CELL GROWTH; CELL INTERACTION; CELL ISOLATION; CELL TYPE; COCULTURE; CONTROLLED STUDY; DOG; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVITY; GENE EXPRESSION; ILIAC CREST; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MATERIAL COATING; MESENCHYMAL STEM CELL; MINERALIZATION; NONHUMAN; TISSUE ENGINEERING; TISSUE REGENERATION;

EID: 84887152723     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2013.09.009     Document Type: Article

References (46)

1. Kanczler J.M., Oreffo R.O. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 2008, 15:100-114.
2. Muschler G.F., Nakamoto C., Griffith L.G. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 2004, 86-A:1541-1558.
3. Ueda M., Yamada Y., Ozawa R., et al. Clinical case reports of injectable tissue-engineered bone for alveolar augmentation with simultaneous implant placement. Int J Periodontics Restorative Dent 2005, 25:129-137.
4. Lee S.H., Coger R.N., Clemens M.G. Antioxidant functionality in hepatocytes using the enhanced collagen extracellular matrix under different oxygen tensions. Tissue Eng 2006, 12:2825-2834.
5. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
6. Kim S., von Recum H. Endothelial stem cells and precursors for tissue engineering: cell source, differentiation, selection, and application. Tissue Eng Part B Rev 2008, 14:133-147.
7. Larrivée B., Karsan A. Involvement of marrow-derived endothelial cells in vascularization. Handb Exp Pharmacol 2007, 180:89-114.
8. Kovacic J.C., Moore J., Herbert A., et al. Endothelial progenitor cells, angioblasts, and angiogenesis-old terms reconsidered from a current perspective. Trends Cardiovasc Med 2008, 18:45-51.
9. Sepúlveda P., Martinez-León J., García-Verdugo J.M. Neoangiogenesis with endothelial precursors for the treatment of ischemia. Transplant Proc 2007, 39:2089-2094.
10. Kalka C., Masuda H., Takahashi T., et al. Transplantation of exvivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000, 97:3422-3427.
11. Kern S., Eichler H., Stoeve J., et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006, 24:1294-1301.
12. Iwata T., Yamato M., Zhang Z., et al. Validation of human periodontal ligament-derived cells as a reliable source for cytotherapeutic use. J Clin Periodontol 2010, 37:1088-1099.
13. Vieira N.M., Brandalise V., Zucconi E., et al. Isolation, characterization, and differentiation potential of canine adipose-derived stem cells. Cell Transplant 2010, 19:279-289.
14. Jung D.I., Ha J., Kang B.T., et al. A comparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury. J Neurol Sci 2009, 285:67-77.
15. Asahara T., Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 2004, 287:C572-C579.
16. Chen D., Zhao M., Mundy G.R. Bone morphogenetic proteins. Growth Factors 2004, 22:233-241.
17. Seck T., Scheppach B., Scharla S., et al. Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs. J Clin Endocrinol Metab 1998, 83:2331-2337.
18. Fuchs S., Ghanaati S., Orth C., et al. Contribution of outgrowth endothelial cells from human peripheral blood on invivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds. Biomaterials 2009, 30:526-534.
19. Brandi M.L., Collin-Osdoby P. Vascular biology and the skeleton. J Bone Miner Res 2006, 21:183-192.
20. Choi I.H., Chung C.Y., Cho T.J., et al. Angiogenesis and mineralization during distraction osteogenesis. J Korean Med Sci 2002, 17:435-447.
21. Garrett R.W., Emerson S.G. Bone and blood vessels: the hard and the soft of hematopoietic stem cell niches. Cell Stem Cell 2009, 4:503-506.
22. Nesselmann C., Ma N., Bieback K., et al. Mesenchymal stem cells and cardiac repair. J Cell Mol Med 2008, 12:1795-1810.
23. Suh W., Kim K.L., Kim J.M., et al. Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells 2005, 23:1571-1578.
24. Dazzi F., Ramasamy R., Glennie S., et al. The role of mesenchymal stem cells in haemopoiesis. Blood Rev 2006, 20:161-171.
25. Ball S.G., Shuttleworth A.C., Kielty C.M. Direct cell contact infl{ligature}uences bone marrow mesenchymal stem cell fate. Int J Biochem Cell Biol 2004, 36:714-727.
26. Huang Y.C., Kaigler D., Rice K.G., et al. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 2005, 20:84-857.
27. Grellier M., Bordenave L., Amédée J. Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering. Trends Biotechnol 2009, 27:562-571.
28. Rouwkema J., De Boer J., van Blitterswijk C.A. Endothelial cells assemble into a 3- dimensional prevascular network in a bone tissue engineering construct. Tissue Eng 2006, 12:2685-2693.
29. Fuchs S., Jiang X., Schmidt H., et al. Dynamic processes involved in the pre-vascularization of silk fibrin constructs for bone regeneration using outgrowth endothelial cells. Biomaterials 2009, 30:1329-1338.
30. Guillotin B., Bourget C., Remy-Zolgadri M., et al. Human primary endothelial cells stimulate human osteoprogenitor cell differentiation. Cell Physiol Biochem 2004, 14:325-332.
31. Tarkka T., Sipola A., Jämsä T., et al. Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J Gene Med 2003, 5:560-566.
32. Kaigler D., Krebsbach P.H., Polverini P.J., et al. Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng 2003, 9:95-103.
33. Bouletreau P.J., Warren S.M., Spector J.A., et al. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg 2002, 109:2384-2397.
34. Belfiore A., Frasca F., Pandini G., et al. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 2009, 30:586-623.
35. Thum T., Hoeber S., Froese S., et al. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res 2007, 100:434-443.
36. Xian L., Wu X., Pang L., et al. Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat Med 2012, 18:1095-1101.
37. Madeddu P. Therapeutic angiogenesis and vasculogenesis for tissue regeneration. Exp Physiol 2005, 90:315-326.
38. Davis G.E., Senger D.R. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 2005, 97:1093-1107.
39. Nagaya N., Fujii T., Iwase T., et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 2004, 287:H2670-H2676.
40. Annabi B., Lee Y.T., Turcotte S., et al. Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells 2003, 21:337-347.
41. Gruber R., Kandler B., Holzmann P., et al. Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells. Tissue Eng 2005, 11:896-903.
42. Holmes K., Roberts O.L., Thomas A.M., et al. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007, 19:2003-2012.
43. Conway E.M., Collen D., Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001, 49:507-521.
44. Huang P.H., Chen Y.H., Wang C.H., et al. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2009, 29:1179-1184.
45. Anderson D.E., Hinds M.T. Extracellular matrix production and regulation in micropatterned endothelial cells. Biochem Biophys Res Commun 2012, 427:159-164.
46. Salani D., Taraboletti G., Rosano L., et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization invivo. Am J Pathol 2000, 157:1703-1711.